Sequential High-Dose Alkylating Therapy and Stem Cell Support for High-Risk Stage III Breast Cancer

386 High-dose chemotherapy with stem cell support in high-risk primary breast cancer. An analysis of the effect on overall survival the Danish experience from a comparison study

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90418-6 ◽

2003 ◽

Vol 1 (5) ◽

pp. S118

Author(s):

T. Palshof ◽

S. Werner Hansen ◽

C. rose ◽

S. Møller ◽

P. Hokland ◽

...

Keyword(s):

Breast Cancer ◽

Overall Survival ◽

Stem Cell ◽

High Risk ◽

High Dose Chemotherapy ◽

High Dose ◽

Comparison Study ◽

Stem Cell Support ◽

Danish Experience ◽

Sequential Treatment Including High-Dose Chemotherapy With Peripheral Blood Stem Cell Support in Patients With High-Risk Stage II-III Breast Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199810000-00022 ◽

1998 ◽

Vol 21 (5) ◽

pp. 523-531 ◽

Cited By ~ 12

Author(s):

Lee S. Schwartzberg ◽

Robert Birch ◽

William H. West ◽

Kurt W. Tauer ◽

Frederick Wittlin ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Peripheral Blood ◽

High Dose Chemotherapy ◽

Stage Ii ◽

High Dose ◽

Stem Cell Support ◽

Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(97)89008-9 ◽

1997 ◽

Vol 33 (3) ◽

pp. 372-378 ◽

Cited By ~ 16

Author(s):

R. Haas ◽

H. Schmid ◽

U. Hahn ◽

S. Hohaus ◽

H. Goldschmidt ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Adjuvant Treatment ◽

Primary Breast Cancer ◽

High Dose ◽

High Dose Therapy ◽

Stem Cell Support ◽

Adjuvant High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Support for High-Risk Primary Breast Cancer: Results from the Italian National Registry

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2013.12.569 ◽

2014 ◽

Vol 20 (4) ◽

pp. 501-506 ◽

Cited By ~ 5

Author(s):

Paolo Pedrazzoli ◽

Giovanni Martinelli ◽

Alessandro Massimo Gianni ◽

Gian Antonio Da Prada ◽

Alberto Ballestrero ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Primary Breast Cancer ◽

High Dose Chemotherapy ◽

National Registry ◽

High Dose ◽

Hematopoietic Stem ◽

Stem Cell Support ◽

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support

International Journal of Cancer ◽

10.1002/ijc.10478 ◽

2002 ◽

Vol 100 (3) ◽

pp. 290-296 ◽

Cited By ~ 20

Author(s):

Manfred Hensel ◽

Andreas Schneeweiss ◽

Hans-Peter Sinn ◽

Gerlinde Egerer ◽

Erich Solomayer ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Cancer Patients ◽

Autologous Blood ◽

High Dose Chemotherapy ◽

High Dose ◽

Breast Cancer Patients ◽

Stem Cell Support ◽

94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer

European Journal of Cancer ◽

10.1016/0959-8049(96)84848-9 ◽

1996 ◽

Vol 32 ◽

pp. S19

Author(s):

H.T. Greinix ◽

W. Linkeach ◽

M. Seifert ◽

E. Kubista ◽

K. Czerwendka ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

Primary Breast Cancer ◽

Autologous Blood ◽

High Dose Chemotherapy ◽

Blood Stem Cell ◽

High Dose ◽

Stem Cell Support ◽

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach

British Journal of Cancer ◽

10.1038/bjc.1995.165 ◽

1995 ◽

Vol 71 (4) ◽

pp. 857-862 ◽

Cited By ~ 26

Author(s):

E van der Wall ◽

WJ Nooijen ◽

JW Baars ◽

MJ Holtkamp ◽

JH Schorangel ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Risk ◽

High Dose ◽

Stem Cell Support ◽

High Risk Breast Cancer ◽

High Risk Breast ◽

Cell Support ◽

Risk Breast Cancer

High-dose chemotherapy and stem-cell support in breast cancer

The Lancet ◽

10.1016/s0140-6736(98)00036-1 ◽

1998 ◽

Vol 352 (9135) ◽

pp. 1220

Author(s):

Paolo Pedrazzoli ◽

Gian Antonio Da Prada ◽

Gioacchino Robustelli della Cuna

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

High Dose Chemotherapy ◽

High Dose ◽

Stem Cell Support ◽

High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704489 ◽

2004 ◽

Vol 33 (10) ◽

pp. 1011-1014 ◽

Cited By ~ 9

Author(s):

A S Buser ◽

D Heim ◽

C Bucher ◽

A Tichelli ◽

A Gratwohl ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

High Dose Chemotherapy ◽

High Dose ◽

Reduced Intensity Conditioning ◽

Stem Cell Support ◽

Refractory Lymphoma ◽

Tumor Debulking ◽

Cell Support ◽

Reduced Intensity

High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study

British Journal of Cancer ◽

10.1054/bjoc.2001.2069 ◽

2001 ◽

Vol 85 (9) ◽

pp. 1240-1246 ◽

Cited By ~ 5

Author(s):

P H Cottu ◽

J M Extra ◽

M Espie ◽

J P Marolleau ◽

A de Roquancourt ◽

...

Keyword(s):

Breast Cancer ◽

Stem Cell ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Peripheral Blood ◽

Phase Ii Study ◽

High Dose ◽

Stem Cell Support ◽